WeVote
Log In

Bill

Bill

SB 2562

Mississippi Veterans PTSD Ibogaine Research Pilot Program; create.

2026 Regular Session Introduced by Jeff Tate

Mississippi creates a pilot program authorizing clinical research into ibogaine treatment for veterans with PTSD, despite the substance's federal Schedule I controlled status.

Referred To Public Health and Welfare
#publichealthandwelfare
0
WeVote Research Nonpartisan
Bill Summary · SB 2562

Legislative bill overview

SB 2562 establishes a pilot research program in Mississippi to study ibogaine—a psychoactive substance derived from African plants—as a potential treatment for PTSD in veterans. The bill creates a framework for conducting clinical research on ibogaine's efficacy and safety within a controlled, regulated environment.

Why is this important

PTSD affects a significant portion of veterans and current treatments don't work for everyone, making alternative therapeutic options potentially valuable. Ibogaine shows promise in preliminary research for trauma treatment, but remains a controlled substance federally, making state-level pilot programs a pathway to gather clinical evidence while maintaining regulatory oversight.

Potential points of contention

  • Federal-state conflict: Ibogaine is a Schedule I controlled substance under federal law, creating legal uncertainty about whether a state pilot can operate independently of federal approval or DEA licensing
  • Safety and liability concerns: Ibogaine carries documented risks including cardiac complications and psychological distress, raising questions about participant protection and medical liability for researchers and the state
  • Efficacy evidence gap: While preliminary studies exist, robust clinical evidence remains limited, and critics may question whether taxpayer funds should support research on unproven treatments when established therapies exist

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.